Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,425 | 1 | 72.2% |
| Food and Beverage | $547.46 | 6 | 27.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ARGENX US, INC. | $1,568 | 2 | $0 (2023) |
| UCB, Inc. | $134.05 | 1 | $0 (2024) |
| GENZYME CORPORATION | $114.84 | 1 | $0 (2023) |
| Sarepta Therapeutics, Inc. | $95.00 | 1 | $0 (2023) |
| Celgene Corporation | $50.00 | 1 | $0 (2023) |
| Kedrion Biopharma, Inc. | $10.27 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $134.05 | 1 | UCB, Inc. ($134.05) |
| 2023 | $413.41 | 5 | ARGENX US, INC. ($143.30) |
| 2022 | $1,425 | 1 | ARGENX US, INC. ($1,425) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $134.05 | General |
| 11/15/2023 | Kedrion Biopharma, Inc. | Albuked (Biological), KOATE, GAMMAKED | Food and Beverage | Cash or cash equivalent | $10.27 | General |
| Category: Critical Care | ||||||
| 11/04/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $143.30 | General |
| Category: Immunology | ||||||
| 07/20/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $114.84 | General |
| 03/20/2023 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $95.00 | General |
| 02/16/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: Hematology | ||||||
| 07/23/2022 | ARGENX US, INC. | — | Consulting Fee | Cash or cash equivalent | $1,425.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 109 | 133 | $30,412 | $11,375 |
| 2022 | 7 | 260 | 294 | $120,275 | $29,899 |
| 2021 | 10 | 465 | 615 | $267,241 | $63,976 |
| 2020 | 5 | 136 | 151 | $68,806 | $15,407 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 41 | $12,300 | $5,407 | 44.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $7,980 | $2,916 | 36.5% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2023 | 13 | 13 | $3,172 | $1,685 | 53.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 25 | 30 | $4,500 | $956.86 | 21.3% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2023 | 24 | 30 | $2,460 | $409.70 | 16.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 85 | 95 | $39,488 | $13,350 | 33.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 32 | 32 | $21,135 | $5,499 | 26.0% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2022 | 32 | 34 | $23,512 | $3,719 | 15.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 25 | 30 | $7,500 | $3,018 | 40.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 44 | 52 | $13,518 | $2,059 | 15.2% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2022 | 11 | 11 | $11,330 | $1,649 | 14.6% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2022 | 31 | 40 | $3,792 | $604.93 | 16.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 119 | 206 | $89,404 | $30,667 | 34.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 44 | 44 | $30,740 | $7,793 | 25.4% |
| 95911 | Nerve transmission studies, 9-10 studies | Facility | 2021 | 61 | 61 | $44,164 | $6,855 | 15.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2021 | 100 | 142 | $37,772 | $5,465 | 14.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 37 | 45 | $11,250 | $5,018 | 44.6% |
| 95913 | Nerve transmission studies, 13 or more studies | Facility | 2021 | 19 | 20 | $20,600 | $3,192 | 15.5% |
| 95910 | Nerve transmission studies, 7-8 studies | Facility | 2021 | 27 | 27 | $15,714 | $2,311 | 14.7% |
| 95912 | Nerve transmission studies, 11-12 studies | Facility | 2021 | 11 | 11 | $9,592 | $1,484 | 15.5% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Facility | 2021 | 34 | 40 | $3,920 | $626.00 | 16.0% |
| 95937 | Testing with stimulation for assessment of function at muscle-nerve junction | Facility | 2021 | 13 | 19 | $4,085 | $565.44 | 13.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 38 | 38 | $27,098 | $6,670 | 24.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 34 | 40 | $17,360 | $5,007 | 28.8% |
| 95911 | Nerve transmission studies, 9-10 studies | Facility | 2020 | 17 | 17 | $12,308 | $1,944 | 15.8% |
About Fang Sun
Fang Sun is a Neuromuscular Medicine healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2015. The National Provider Identifier (NPI) number assigned to this provider is 1831585322.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Fang Sun has received a total of $1,972 in payments from pharmaceutical and medical device companies, with $134.05 received in 2024. These payments were reported across 7 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($1,425).
As a Medicare-enrolled provider, Sun has provided services to 970 Medicare beneficiaries, totaling 1,193 services with total Medicare billing of $120,658. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Neuromuscular Medicine
- Other Specialties Neuromuscular Medicine
- Location Pittsburgh, PA
- Active Since 04/10/2015
- Last Updated 10/06/2022
- Taxonomy Code 2084N0008X
- Entity Type Individual
- NPI Number 1831585322
Products in Payments
- VYVGART (Drug) $143.30
- REBLOZYL (Biological) $50.00
- Albuked (Biological) $10.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.